Methods for the detection and determination of ligands

• US 4,228,237 A
• Filed: 09/21/1978
• Issued: 10/14/1980
• Est. Priority Date: 09/21/1978
• Status: Expired due to Term

• Current Assignee: American Hoechst Corporation (Sanofi )
• Original Assignee: Calbiochem-Behring Corporation (Celanese Corporation)
• Inventors: Malmros, Mark K., Hevey, Richard C.
• Primary Examiner(s): Wiseman, Thomas G.
• Application Number:
  US05/944,254
• Time in Patent Office: 754 Days
• Field of Search: 435/7, 435/188, 435/177, 424/12, 23/230 B
• US Class Current: 435/5
• CPC Class Codes: G01N 33/531 Production of immunochemical test materials
• CPC Class Codes: G01N 33/532 Production of labelled immunochemicals
• CPC Class Codes: G01N 33/54306 Solid-phase reaction mechanisms
• CPC Class Codes: Y10S 436/81 Tube, bottle, or dipstick
• CPC Class Codes: Y10S 436/815 Test for named compound or class of compounds

Abstract

A method for determining the presence of a ligand in a liquid medium which utilizes enzyme labeled avidin and biotin labeled reagent in a specific binding process wherein the ligand to be detected is contacted with an insoluble phase containing specific binding substance for the ligand. Various protocols may be used to assay the resulting enzyme activity which is related to the amount of ligand in the liquid medium.

Claims

1. A method of determining a ligand in a liquid medium suspected of containing same, which method comprises:

(a) providing an insoluble phase containing a specific binding substance for said ligand;

(b) incubating said insoluble phase with the following reagents;

(i) liquid medium suspected of containing said ligand;

(ii) biotin labeled specific binding substance for said ligand; and

(iii) enzyme labeled avidin;

(c) separating unreacted reagents from said insoluble phase after incubation; and

(d) determining the enzyme activity of either said insoluble phase or separated unreacted reagent whereby said activity is related to the amount of ligand in said liquid medium.

2. A method according to claim 1 wherein step (b) comprises incubating said insoluble phase with reagents (i), (ii) and (iii) in the presence of one another.

3. A method according to claim 1 wherein step (b) comprises incubating said insoluble phase with reagents (i), (ii), and (iii) in the order indicated;

step (c) comprises separating unreacted reagent from said insoluble phase after each incubation; and

step (d) comprises determining the enzyme activity of either said insoluble phase or separated unreacted enzyme labeled avidin.

4. A method according to claim 1 wherein said ligand is an antigen.

5. A method according to claim 4 wherein said antigen is alpha₁ fetoprotein.

6. A method according to claim 1 wherein said ligand is an antibody.

25. A method according to claims 1, 2, 3, 4, 5 or 6 wherein said insoluble phase, said biotin labeled specific binding substance and said enzyme labeled avidin are each present during incubation in excess of the total amount of ligand in the liquid medium.

7. A method for determining a ligand in a liquid medium suspected of containing same, which method comprises:

(a) providing an insoluble phase containing a specific binding substrate for said ligand;

(b) incubating said insoluble phase with the following reagents;

(i) liquid medium suspected of containing said ligand; and

(ii) biotin labeled specific binding substance for said ligand bound to enzyme labeled avidin;

(c) separating unreacted reagents from said insoluble phase after incubation; and

(d) determining the enzyme activity of either said insoluble phase or separated unreacted reagent whereby said activity is related to the amount of ligand in said liquid medium.

8. A method according to claim 7 wherein step (b) comprises incubating said insoluble phase with reagents (i) and (ii) in the presence of one another.

9. A method according to claim 7 wherein step (b) comprises incubating said insoluble phase with reagents (i) and (ii) in the order indicated;

step (c) comprises separating unreacted reagent from said insoluble phase after each incubation; and

step (d) comprises determining the enzyme activity of either said insoluble phase or separated unreacted biotin labeled specific binding substance bound to enzyme labeled avidin.

10. A method according to claim 7 wherein said ligand is an antigen.

11. A method according to claim 10 wherein said antigen is human IgE.

12. A method according to claim 10 wherein said antigen is alpha₁ fetoprotein.

13. A method according to claim 7 wherein said ligand is an antibody.

14. A method according to claim 13 wherein said antibody is humann anti-rubella IgG.

15. A method according to claim 14 wherein the specific binding substance contained in said insoluble phase is rubella antigen and the specific binding substance contained in reagent (ii) is anti human IgG.

26. A method according to claims 7, 8, 9, 10, 11, 12, 13, 14, or 15 wherein said insoluble phase and said biotin labeled specific binding substance bound to enzyme labeled avidin are each present during incubation in excess of the total amount of ligand in the liquid medium.

16. A method for determining a ligand in a liquid medium suspected of containing same, which method comprises:

(a) providing an insoluble phase containing a specific binding substance for said ligand;

(b) incubating said insoluble phase with the following reagents;

(i) (A) liquid medium suspected of containing said ligand and (B) a known quantity of biotin labeled ligand; and

(ii) enzyme labeled avidin;

(c) separating unreacted reagents from said insoluble phase after incubation; and

(d) determining the enzyme activity of either said insoluble phase or separated unreacted reagent whereby said activity is related to the amount of ligand in said liquid medium.

17. A method according to claim 16 wherein step (b) comprises incubating said insoluble phase with reagents (i) and (ii) in the presence of one another.

18. A method according to claim 16 wherein step (b) comprises incubating said insoluble phase with reagents (i) and (ii) in the order indicated;

step (c) comprises separating unreacted reagent from said insoluble phase after each incubation; and

step (d) comprises determining the enzyme activity of either said insoluble phase or separated unreacted enzyme labeled avidin.

19. A method according to claim 16 wherein said ligand is an antigen.

20. A method according to claim 19 wherein said antigen is human IgG.

21. A method according to claim 16 wherein said ligand is an antibody.

27. A method according to claims 16, 17, 18, 19, 20 or 21 wherein said ligand to be determined, said biotin labeled ligand and said enzyme labeled avidin are each present during incubation in excess of said insoluble phase, the quantity of biotin labeled ligand not exceeding the smallest quantity of ligand to be determined in the liquid medium.

22. A method for determining a ligand in a liquid medium suspected of containing same, which method comprises:

(a) providing an insoluble phase containing a specific binding substance for said ligand;

(b) incubating said insoluble phase with a reagent comprising (A) liquid medium suspected of containing said ligand and (B) a known quantity of biotin labeled ligand bound to enzyme labeled avidin;

(c) separating unreacted reagent from said insoluble phase after incubation; and

(d) determining the enzyme activity of either said insoluble phase or separated unreacted reagent whereby said activity is related to the amount of ligand in said liquid medium.

23. A method according to claim 22 wherein said ligand is an antigen.

24. A method according to claim 22 wherein said ligand is an antibody.

28. A method according to claims 22, 23 or 24 wherein said ligand to be determined and said biotin labeled ligand bound to enzyme labeled avidin are each present during incubation in excess of said insoluble phase, the quantity of biotin labeled ligand bound to enzyme labeled avidin not exceeding the smallest quantity of ligand to be determined in the liquid medium.